Patent · US Active

Antibodies that inhibit metalloproteins

US8697078B2 · kind B2 · utility

1Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 27, 2011
Grant dateApr 15, 2014
Priority date
Expiry dateJan 27, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to antibodies which recognize [2(2-aminoethylcarbomoyl)-ethoxymethyl]-tris-[2-N-(3-imidazol-1-yl-propyl))-ethoxymethyl]methane, a hapten molecule which closely mimics the local structure and conformation of the reactive zinc site in matrix metalloproteinases.An antibody is disclosed which comprises an antigen recognition region which comprises six CDR amino acid sequences selected from the group consisting of SEQ ID NOs: 4-15. Uses thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.